959 top medical experts on Mood Disorders across 57 countries and 39 U.S. states, including 878 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Mood Disorders: Those disorders that have a disturbance in mood as their predominant feature.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Mental Disorders (4,660) and Narrower Categories: Cyclothymic Disorder (747), Depressive Disorder (5,137).
  4. Clinical Trials ClinicalTrials.gov : at least 447 including 8 Active, 259 Completed, 90 Recruiting
  5. Synonyms: Affective Disorders


  

        

                    


    These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads, screen scraping or using the data) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

  1. Sanacora, Gerard   Psychiatry   Google Publications
    Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA. Top Hospital
    Physician  Highly Cited  Highly Published  Clinical Trial  Review 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 68/100
    Disclosed payments in 2021 from 10 biomedical companies, totalling $11,540, including $4,400 from  Sage Therapeutics, Inc.
    Subjects: Ketamine; Antidepressive Agents; Depressive Disorder, Treatment-Resistant; Glutamic Acid; Obsessive-Compulsive Disorder
    Categories: Drug Therapy; Therapeutic Use; Metabolism; Genetics; Adverse Effects; Drug Effects
    Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. (2012)
    A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders. (2017)

  2. Frye, Mark A   Psychiatry   ClinicalTrials.gov Google Publications
    Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN 55905, USA. Top Hospital
    Physician  Highly Cited  Highly Published 
    Medical school: University of Minnesota Medical School (MD, 1990)
    Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 79.7/100
    Subjects: Bipolar Disorder; Parkinson Disease; Alcoholism; Anxiety Disorders; Catatonia
    Categories: Genetics; Drug Therapy; Epidemiology; Psychology; Statistics & Numerical Data; Therapy
    A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders. (2017)
    A 20 Year Practice Review of Electroconvulsive Therapy for Adolescents. (2016)

  3. Rubinow, David R   Psychiatry   Google Publications
    Department of Psychiatry, University of North Carolina, Chapel Hill, NC, USA. .
    Physician  Highly Cited  Highly Published  Clinical Trial 
    Relevant US NIH Grant Funding: $927,770 over the last 5 years
    Medical school: University of Connecticut School of Medicine (MD, 1975)
    Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 76/100
    Disclosed payments in 2021 from 3 biomedical companies, totalling $11,498, including $11,498 from  Sage Therapeutics, Inc.
    Subjects: Premenstrual Syndrome; Affect; Gonadal Steroid Hormones; Reproduction; Sex Characteristics
    Categories: Metabolism; Psychology; Immunology; Physiology; Etiology; Therapeutic Use
    Sex differences and the neurobiology of affective disorders. (2019)
    Reproductive Steroid Regulation of Mood and Behavior. (2016)

  4. Wilkinson, Samuel T   Psychiatry   Google Publications
    Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA; Connecticut Mental Health Center, New Haven, CT, USA. Electronic address: .
    Physician  Clinical Trial  Review 
    Relevant US NIH Grant Funding: $1,762,458 over the last 5 years
    Medicare MIPS (Merit-based Incentive Payment System) rating: 83/100
    Disclosed payments in 2021 from 4 biomedical companies, totalling $3,020, including $3,020 from  Sage Therapeutics, Inc.
    Subjects: Ketamine; Antidepressive Agents; Anesthetics, Dissociative; Depressive Disorder, Treatment-Resistant; Glutamic Acid
    Categories: Drug Therapy; Therapeutic Use; Adverse Effects; Metabolism; Chemically Induced; Statistics & Numerical Data
    A new generation of antidepressants: an update on the pharmaceutical pipeline for novel and rapid-acting therapeutics in mood disorders based on glutamate/GABA neurotransmitter systems. (2019)
    Acute and Longer-Term Outcomes Using Ketamine as a Clinical Treatment at the Yale Psychiatric Hospital. (2018)

  5. Calabrese, Joseph R   Psychiatry  Google Publications
    Department of Psychiatry, Case Western Reserve School of Medicine, Cleveland, OH, USA.
    Physician  Clinical Trial 
    Subjects: Anxiety Disorders; Anhedonia; Benzamides; Mass Screening; Military Personnel
    Categories: Drug Therapy; Therapeutic Use; Analogs & Derivatives; Diagnosis; Epidemiology; Etiology
    A randomized proof-of-mechanism trial applying the 'fast-fail' approach to evaluating κ-opioid antagonism as a treatment for anhedonia. (2020)
    Composite International Diagnostic Interview screening scales for DSM-IV anxiety and mood disorders. (2013)

  6. Teixeira, Antonio Lucio   Psychiatry   Google Publications
    Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center, Houston, TX 77054, United States.
    Physician  Highly Cited  Highly Published  Review 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 63/100
    Subjects: Anxiety Disorders; Multiple Sclerosis; Schizophrenia; Brain-Derived Neurotrophic Factor; Cognition Disorders
    Categories: Immunology; Blood; Metabolism; Epidemiology; Physiopathology; Psychology
    Inflammation in psychiatric disorders: what comes first? (2019)
    Role of Kynurenine pathway and its metabolites in mood disorders: A systematic review and meta-analysis of clinical studies. (2018)

  7. Correll, Christoph U   Psychiatry   Google Publications
    Department of Psychiatry, Northwell Health, The Zucker Hillside Hospital, Glen Oaks, New York, USA.
    Physician  Highly Published  Clinical Trial  Review 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 88.9/100
    Disclosed payments in 2021 from 41 biomedical companies, totalling $170,557.69, including $48,540.9 from  Teva Pharmaceuticals USA, Inc.
    Subjects: Psychotic Disorders; Psychotropic Drugs; Activities of Daily Living; Adrenergic Uptake Inhibitors; Antipsychotic Agents
    Categories: Therapy; Drug Therapy; Analogs & Derivatives; Genetics; Administration & Dosage; Adverse Effects
    Role of social media and the Internet in pathways to care for adolescents and young adults with psychotic disorders and non-psychotic mood disorders. (2017)
    A meta-analysis of temperament and character dimensions in patients with mood disorders: Comparison to healthy controls and unaffected siblings. (2016)

  8. Schatzberg, Alan F   Psychiatry  Google Publications
    Department of Psychiatry & Behavioural Science, Stanford University, Palo Alto, CA, United States. Top Hospital
    Physician  Highly Cited  Review 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 65/100
    Disclosed payments in 2021 from 28 biomedical companies, totalling $30,740.47, including $11,573.33 from  Otsuka Pharmaceutical Development & Commercialization, Inc.
    Subjects: Anxiety Disorders; Ketamine; Psychotic Disorders; Antidepressive Agents; Brain
    Categories: Metabolism; Drug Therapy; Diagnosis; Therapeutic Use; Physiopathology; Physiology
    A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders. (2017)
    Ketamine: promising path or false prophecy in the development of novel therapeutics for mood disorders? (2015)

  9. Nierenberg, Andrew A   Psychiatry  ClinicalTrials.gov Google Publications
    Dauten Family Center for Bipolar Treatment Innovation, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusettes, USA. Top Hospital
    Physician  Highly Published  Clinical Trial 
    Medical school: Albert Einstein College of Medicine of Yeshiva University (MD, 1980)
    Medicare Accepted
    Disclosed payments in 2021 from 5 biomedical companies, totalling $4,340, including $2,340 from  Sage Therapeutics, Inc.
    Subjects: Bipolar Disorder; Anxiety Disorders; Depression; Behavior Observation Techniques; COVID-19
    Categories: Diagnosis; Psychology; Therapy; Analogs & Derivatives; Drug Therapy; Instrumentation
    Composite International Diagnostic Interview screening scales for DSM-IV anxiety and mood disorders. (2013)
    Behavioral Indicators on a Mobile Sensing Platform Predict Clinically Validated Psychiatric Symptoms of Mood and Anxiety Disorders. (2017)

  10. Soares, Jair C   Psychiatry  Google Publications
    Department of Psychiatry and Behavioural Neurosciences, University of Texas, Houston, TX, USA.
    Physician 
    Disclosed payments in 2021 from 3 biomedical companies, totalling $1,848.92, including $1,650 from  Merck Sharp & Dohme Corporation
    Subjects: Algorithms; Bipolar Disorder; Brain-Derived Neurotrophic Factor; Hippocampus; Machine Learning
    Categories: Genetics; Pathology; Psychology; Statistics & Numerical Data
    Hippocampal subfield volumes in mood disorders. (2017)
    Identifying a clinical signature of suicidality among patients with mood disorders: A pilot study using a machine learning approach. (2016)

  11. Mathew, Sanjay J   Psychiatry  Google Publications
    Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX, USA. Top Hospital
    Physician  Highly Cited  Clinical Trial 
    Disclosed payments in 2021 from 3 biomedical companies, totalling $2,825, including $1,825 from  Sage Therapeutics, Inc.
    Subjects: Anxiety Disorders; Receptors, Metabotropic Glutamate; Anhedonia; Benzamides; Central Nervous System Agents
    Categories: Drug Therapy; Therapeutic Use; Antagonists & Inhibitors; Agonists; Drug Effects
    A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders. (2017)
    A randomized proof-of-mechanism trial applying the 'fast-fail' approach to evaluating κ-opioid antagonism as a treatment for anhedonia. (2020)

  12. Perlis, Roy H   Psychiatry   Google Publications
    Center for Quantitative Health, Center for Human Genetic Research and Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA. Top Hospital
    Physician 
    Relevant US NIH Grant Funding: $2,199,972 over the last 5 years
    Subjects: Anxiety Disorders; COVID-19; Chromatin Assembly and Disassembly; Depressive Disorder, Major; Epigenesis, Genetic
    Categories: Genetics; Complications; Methods; Psychology
    Mood Disorders and Outcomes of COVID-19 Hospitalizations. (2021)
    Genome-wide association study of suicide attempts in mood disorder patients. (2010)

  13. Postolache, Teodor T   Psychiatry  ClinicalTrials.gov Google Publications
    Mood and Anxiety Program, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland, USA.
    Physician 
    Medical school: Other (MD, 1982)
    Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 92/100
    Subjects: Amish; Dyssomnias; Suicide; Antibodies, Protozoan; Anxiety Disorders
    Categories: Psychology; Complications; Etiology; Epidemiology; Blood; Genetics
    Association of seropositivity for influenza and coronaviruses with history of mood disorders and suicide attempts. (2011)
    Relationship Between Toxoplasma gondii and Mood Disturbance in Women Veterans. (2015)

  14. Szabo, Steven T   Psychiatry  Google Publications
    Departments of Psychiatry and Behavioral Sciences and Radiology, Duke University School of Medicine, Durham, NC, USA. Top Hospital
    Physician  Clinical Trial  Review 
    Disclosed payments in 2021 from 2 biomedical companies, totalling $37.61, including $37.61 from  Lundbeck LLC
    Subjects: Anhedonia; Antidepressive Agents; Benzamides; Excitatory Amino Acid Antagonists; Ketamine
    Categories: Pharmacology; Therapeutic Use; Antagonists & Inhibitors; Drug Therapy; Drug Effects
    A randomized proof-of-mechanism trial applying the 'fast-fail' approach to evaluating κ-opioid antagonism as a treatment for anhedonia. (2020)
    Updates on Preclinical and Translational Neuroscience of Mood Disorders: A Brief Historical Focus on Ketamine for the Clinician. (2019)

  15. Phillips, Mary L   Psychiatry  Google Publications
    University of Pittsburgh, Department of Psychiatry, Loeffler Building, Room 304, 121 Meyran Ave, Pittsburgh, PA 15213, USA.
    Physician  Highly Published 
    Relevant US NIH Grant Funding: $10,666,161 over the last 5 years
    Subjects: Magnetic Resonance Imaging; Bipolar Disorder; Child of Impaired Parents; Depression; Prefrontal Cortex
    Categories: Pathology; Psychology; Diagnostic Imaging; Diagnosis; Metabolism; Methods
    Prefrontal cortex markers of suicidal vulnerability in mood disorders: a model-based structural neuroimaging study with a translational perspective. (2015)
    Subcortical nuclei volumes in suicidal behavior: nucleus accumbens may modulate the lethality of acts. (2016)

  16. Mojtabai, Ramin   Psychiatry   Google Publications
    Mental Health Department, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
    Physician  Highly Published 
    Subjects: Alcohol Drinking; Alcohol-Related Disorders; Alcoholism; Anxiety Disorders; Self Medication
    Categories: Epidemiology; Psychology; Statistics & Numerical Data; Drug Therapy; Adverse Effects; Diagnosis
    A prospective assessment of reports of drinking to self-medicate mood symptoms with the incidence and persistence of alcohol dependence. (2013)
    Cigarette smoking and onset of mood and anxiety disorders. (2013)

  17. Lewis, Charles P   Psychiatry   Google Publications
    Department of Psychiatry and Psychology, Division of Child and Adolescent Psychiatry, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. Electronic address: . Top Hospital
    Physician 
    Subjects: Transcranial Direct Current Stimulation; Bipolar Disorder; Chromosomes, Human, Pair 3; Genetic Predisposition to Disease; Neuronal Plasticity
    Categories: Genetics; Adverse Effects; Methods; Therapy
    The genetics of affective disorder and suicide. (2010)
    Transcranial Direct Current Stimulation: Mechanisms and Psychiatric Applications. (2019)

  18. Stoddard, Joel   Psychiatry  ClinicalTrials.gov Google Publications
    University of Colorado, Anschutz Medical Campus, Aurora, Colorado.
    Physician  Clinical Trial 
    Relevant US NIH Grant Funding: $1,190,177 over the last 5 years
    Subjects: Irritable Mood; Anxiety Disorders; Adolescent Behavior; Anger; Attention
    Categories: Physiology; Physiopathology; Methods; Therapy
    Irritability in child and adolescent anxiety disorders. (2014)
    Attention bias to threat faces in severe mood dysregulation. (2014)

  19. Baldessarini, Ross J   Psychiatry   Google Publications
    International Consortium for Research on Mood & Psychotic Disorders, McLean Hospital, Belmont, MA, USA; Mailman Research Center 3, McLean Hospital, 115 Mill Street, Belmont, MA 02478-9106, USA; Department of Psychiatry, Harvard Medical School, Boston, MA, USA. Top Hospital
    Physician 
    Subjects: Antipsychotic Agents; Depressive Disorder, Major; Suicide; Antimanic Agents; Benzodiazepines
    Categories: Drug Therapy; Epidemiology; Psychology; Therapeutic Use; Adverse Effects; Physiology
    Episodes of mood disorders in 2,252 pregnancies and postpartum periods. (2011)
    Antisuicidal Effects in Mood Disorders: Are They Unique to Lithium? (2018)

  20. Crum, Rosa M   Psychiatry   Google Publications
    Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA.  Top Hospital
    Physician 
    Subjects: Alcohol Drinking; Alcohol-Related Disorders; Alcoholism; Self Medication; Anxiety Disorders
    Categories: Epidemiology; Psychology; Adverse Effects; Etiology; Economics; Statistics & Numerical Data
    A prospective assessment of reports of drinking to self-medicate mood symptoms with the incidence and persistence of alcohol dependence. (2013)
    Cigarette smoking and onset of mood and anxiety disorders. (2013)

Note:
  1. These experts have limited publications on this topic in our database, so expertise assessment may not be accurate.
  2. Only the top 20 experts are shown. You may filter your results or use the geolocation tabs. Contact us to purchase the entire list.
These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads or screen scraping) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

);